• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Levetiracetam Teva
    / Teva


    Active Ingredient
    Levetiracetam 250, 500, 1000 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    60 X 250 mg

    partial basket chart 83513 12427

    Tablets

    60 X 500 mg

    partial basket chart 83514 12428

    Tablets

    60 X 1000 mg

    partial basket chart 83515 12429

    Related information


    Dosage

    See prescribing information for full details.


    Indications

    As adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.As adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.As monotherapy in the treatment of partial onset seizures with or without secondary generalization in patients from 16 years of age with newly diagnosed epilepsy.In the treatment of primary generalized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.


    Contra-Indications

    Known hypersensitivity to levetiracetam, to other pyrrolidone derivatives, or to any other ingredient of the preparation.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE